Home › Immune System and Disorders › Arkansas
Immune System and Disorders clinical trials in Arkansas
3 studies for Immune System and Disorders are looking for participants at sites in Arkansas.
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Genesis Cancer and Blood Institute - SCRI, Hot Springs
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Genesis Cancer and Blood Institute - SCRI, Hot Springs
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.